(Q51942429)

18 April 2018

title

Medical and productivity costs of anxiety disorders: case control study. (English)

1 reference

18 April 2018

author name string

Martin Marciniak

1

1 reference

18 April 2018

Maureen J Lage

2

1 reference

18 April 2018

Ronald P Landbloom

3

1 reference

18 April 2018

Eduardo Dunayevich

4

1 reference

18 April 2018

Lee Bowman

5

1 reference

18 April 2018

publication date

1 January 2004

1 reference

18 April 2018

published in

Depression and Anxiety

1 reference

18 April 2018

volume

19

1 reference

18 April 2018

issue

2

1 reference

18 April 2018

page(s)

112-120

1 reference

18 April 2018

Economic consequences of comorbid depression, anxiety, and allergic rhinitis

cites work

1 reference

Utilization of medical specialists by anxiety disorder patients

21 January 2018

1 reference

Past-year use of outpatient services for psychiatric problems in the National Comorbidity Survey.

21 January 2018

1 reference

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

Psychiatric disorder onset and first treatment contact in the United States and Ontario.

21 January 2018

1 reference

Health care costs associated with depressive and anxiety disorders in primary care.

21 January 2018

1 reference

Health care use and at-work productivity among employees with mental disorders.

21 January 2018

1 reference

7 January 2021

Using healthcare claims data for outcomes research and pharmacoeconomic analyses

1 reference

7 January 2021

Gender differences in phobias: Results of the ECA community survey

1 reference

7 January 2021

Panic disorder and asthma

1 reference

7 January 2021

Chronic physical illness, psychiatric disorder and disability in the workplace.

1 reference

7 January 2021

Economic costs of anxiety disorders.

1 reference

7 January 2021

The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large U.S. employers in 1999.

1 reference

7 January 2021

The economic burden of anxiety disorders in the 1990s.

1 reference

7 January 2021

A neural model of memory impairment in diffuse cerebral atrophy.

1 reference

7 January 2021

Lost productivity among full-time workers with mental disorders

1 reference

7 January 2021

Prevalence of symptoms of depression and anxiety in a diabetes clinic population.

1 reference

7 January 2021

Anxiety and Its Association With Depression Among Institutionalized Elderly

1 reference

7 January 2021

Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia

1 reference

7 January 2021

Productivity and medical costs of diabetes in a large employer population.

1 reference

7 January 2021

A twin study of generalized anxiety disorder and major depression.

1 reference

7 January 2021

Syndrome comorbidity in patients diagnosed with a DSM-III-R anxiety disorder

1 reference

7 January 2021

The civilian labor market experiences of Vietnam-era veterans: the influence of psychiatric disorders

1 reference

7 January 2021

Cost of anxiety disorders: impact of comorbidity.

1 reference

7 January 2021

Affective, substance use, and anxiety disorders in persons with arthritis, diabetes, heart disease, high blood pressure, or chronic lung conditions

1 reference

7 January 2021

Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?

1 reference

7 January 2021

Identifiers

DOI

10.1002/DA.10131

1 reference

18 April 2018

1 reference

18 April 2018